Study: Endometriosis Patients Report Subjective Benefits from Marijuana

Phoenix, AZ: The use of either cannabis or cannabis-related products is associated with subjective benefits in women with endometriosis, according to survey data published in the Journal of Minimally Invasive Oncology.

Investigators affiliated with St. Joseph’s Hospital and Medical Center in Phoenix, Arizona surveyed the attitudes in 364 patients with endometriosis.

Authors reported: “Use of medical marijuana and CBD amongst women with endometriosis is common. Both marijuana and CBD are reported as moderately or very effective for pelvic pain by the majority of women who have tried them, with marijuana reported as more effective than CBD.”

Separate survey data published in January in the journal BMC Complementary and Alternative Medicine reported that the use of cannabis was the most effective self-management strategy engaged in by endometriosis patients.

A 2017 review paper on the subject of cannabinoids and endometriosis concluded: “Pain management for patients with endometriosis needs to be more effective, target the hormonal and immunologic environment, downregulate proliferation while enhancing apoptosis, and normalize the invasive mechanisms and neuroangiogenesis processes. ECS (endocannabinoid system) modulation appears to be a good therapeutic strategy by potentially combining all these factors.”

Full text of the study, “Self-reported efficacy of cannabis for endometriosis pain,” appears in the Journal of Minimally Invasive Oncology.